8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-a]quinoxalinone and related compounds: Synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor

被引:79
作者
Ohmori, J
ShimizuSasamata, M
Okada, M
Sakamoto, S
机构
[1] Inst. for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 305, 21, Miyukigaoka
关键词
D O I
10.1021/jm960664c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As a part of our program to discover novel antagonists for the AMPA subtype of EAA receptors, we designed and synthesized a series of heterocyclic-fused imidazolylquinoxalinones 5a-c, 9, 11, 14a-e, and 18 which led from 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (1a . HCl, YM90K) by replacement of its amide with the imidazole and triazole rings. Their activity was evaluated by inhibiting [H-3]AMPA binding from rat whole brain. As a result, it appeared that 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidadazo[1 ,2-a]quinoxalinone (5a) and its [1,2,4]triazolo[4,3-a] analogue 14a possessed high affinity for AMPA receptors with K-i values of 0.057 and 0.19 mu M, respectively, similar to the activity of 1a and NBQX (2) (1a, K-i = 0.084 mu M; 2, K-i = 0.060 mu M). In contrast, 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,5- a]quinoxalinone (5b) and 7-(1H-imidazol-1-yl)-8-nitro-4(5H)-[1,2,4]triazolo[4,3-a]quinoxalinone (18) showed no or weak affinity for the receptors. Hence, we deduced that the nitrogen atom of the fused heterocycles at the 3-position of 5a and 14a plays an essential role as hydrogen bond accepters in binding to AMPA receptors, whereas their amides act as proton donors. From the SAR on 1-alkyl derivatives of 5a and 14a, it was indicated that introduction of suitable 1-alkyl substituents led to a severalfold improved AMPA affinity. A computational study on a model of water-quinoxaline complexes, a mimic of the putative hydrogen-bonding interaction between the receptors and quinoxalines, indicated that the different affinities of 5a, 14a, la, and 19 for the AMPA receptor may depend on, at least in part, each stabilization energy for the interaction. On this basis, we propose a pharmacophore model of AMPA receptors for the binding of the imidazolylquinoxaline derivatives. The heterocyclic-fused quinoxalinones 5a,c and 9 showed potent inhibitory activity in KA-induced toxicity for hippocampal cell culture with IC50 values of 0.30, 0.32, and 0.30 mu M, respectively (1a, 0.81 mu M; 2, 0.38 mu M). Moreover 5a possesses over 5000-fold AMPA selectivity against both the NMDA receptor and the glycine site on the NMDA receptor.
引用
收藏
页码:2053 / 2063
页数:11
相关论文
共 43 条
[1]   SYNTHESIS OF 1,4,7,8,9,10-HEXAHYDRO-9-METHYL-6-NITROPYRIDO[3,4-F]-QUINOXALINE-2,3-DIONE AND RELATED QUINOXALINEDIONES - CHARACTERIZATION OF ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (AND N-METHYL-D-ASPARTATE) RECEPTOR AND ANTICONVULSANT ACTIVITY [J].
BIGGE, CF ;
MALONE, TC ;
BOXER, PA ;
NELSON, CB ;
ORTWINE, DF ;
SCHELKUN, RM ;
RETZ, DM ;
LESCOSKY, LJ ;
BOROSKY, SA ;
VARTANIAN, MG ;
SCHWARZ, RD ;
CAMPBELL, GW ;
ROBICHAUD, LJ ;
WATJEN, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (19) :3720-3740
[2]   3-NITRO-3,4-DIHYDRO-2(1H)-QUINOLONES - EXCITATORY AMINO-ACID ANTAGONISTS ACTING AT GLYCINE-SITE NMDA AND (RS)-ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS [J].
CARLING, RW ;
LEESON, PD ;
MOORE, KW ;
SMITH, JD ;
MOYES, CR ;
MAWER, IM ;
THOMAS, S ;
CHAN, T ;
BAKER, R ;
FOSTER, AC ;
GRIMWOOD, S ;
KEMP, JA ;
MARSHALL, GR ;
TRICKLEBANK, MD ;
SAYWELL, KL .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) :3397-3408
[3]   THE ANTICONVULSANT EFFECT OF THE NON-NMDA ANTAGONISTS, NBQX AND GYKI-52466, IN MICE [J].
CHAPMAN, AG ;
SMITH, SE ;
MELDRUM, BS .
EPILEPSY RESEARCH, 1991, 9 (02) :92-96
[4]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[5]   NOVEL COMPOUNDS POSSESSING POTENT CAMP AND CGMP PHOSPHODIESTERASE INHIBITORY ACTIVITY - SYNTHESIS AND CARDIOVASCULAR EFFECTS OF A SERIES OF IMIDAZO[1,2-A]QUINOXALINONES AND IMIDAZO[1,5-A]QUINOXALINONES AND THEIR AZA ANALOGS [J].
DAVEY, DD ;
ERHARDT, PW ;
CANTOR, EH ;
GREENBERG, SS ;
INGEBRETSEN, WR ;
WIGGINS, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) :2671-2677
[6]   Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-Dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties [J].
Desos, P ;
Lepagnol, JM ;
Morain, P ;
Lestage, P ;
Cordi, AA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :197-206
[7]   Recently developed neuroprotective therapies for acute stroke - A qualitative systematic review of clinical trials [J].
Dorman, PJ ;
Counsell, CE ;
Sandercock, PAG .
CNS DRUGS, 1996, 5 (06) :457-474
[8]   THE NEUROPROTECTIVE ACTION OF DIZOCILPINE (MK-801) IN THE RAT MIDDLE CEREBRAL-ARTERY OCCLUSION MODEL OF FOCAL ISCHEMIA [J].
GILL, R ;
BRAZELL, C ;
WOODRUFF, GN ;
KEMP, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (04) :2030-2036
[9]   THE NEUROPROTECTIVE ACTIONS OF 2,3-DIHYDROXY-6-NITRO-7-SULFAMOYL-BENZO(F)QUINOXALINE (NBQX) IN A RAT FOCAL ISCHEMIA MODEL [J].
GILL, R ;
NORDHOLM, L ;
LODGE, D .
BRAIN RESEARCH, 1992, 580 (1-2) :35-43
[10]   THE BINDING OF [AMPA-H-3, A STRUCTURAL ANALOG OF GLUTAMIC-ACID, TO RAT-BRAIN MEMBRANES [J].
HONORE, T ;
LAURIDSEN, J ;
KROGSGAARDLARSEN, P .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (01) :173-178